[go: up one dir, main page]

MX2017010806A - Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion. - Google Patents

Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion.

Info

Publication number
MX2017010806A
MX2017010806A MX2017010806A MX2017010806A MX2017010806A MX 2017010806 A MX2017010806 A MX 2017010806A MX 2017010806 A MX2017010806 A MX 2017010806A MX 2017010806 A MX2017010806 A MX 2017010806A MX 2017010806 A MX2017010806 A MX 2017010806A
Authority
MX
Mexico
Prior art keywords
beta
metformin
acid
revesterol
glicirretinic
Prior art date
Application number
MX2017010806A
Other languages
English (en)
Inventor
Esther Dragustinovis Ruiz Maria
Original Assignee
Atso Corp Affairs S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atso Corp Affairs S A De C V filed Critical Atso Corp Affairs S A De C V
Priority to MX2017010806A priority Critical patent/MX2017010806A/es
Publication of MX2017010806A publication Critical patent/MX2017010806A/es
Priority to PCT/MX2018/050020 priority patent/WO2019039931A1/es
Priority to PCT/IB2018/056324 priority patent/WO2019038678A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones que contienen como principios activos al compuesto ácido 18-beta-Glicirretinico (GA-18ß)en combinación con la fitoalexina resveratrol y la biguadina metformina, utilizando como transportadores nano-estructuras de carbono en una solución polimérica de gel termo-sensible, adicionado con extracto sobrenadante de Lactobacillous sp para su aplicación tópica en diversas regiones anatómicas afectadas por lesiones de tipo displásico y neoplásico, incluyendo la región genital de mujeres y varones con lesiones causadas por diversos ADN virus, como el virus del papiloma humano, herpes virus y cáncer de diversa etiología en los mismos.
MX2017010806A 2017-08-22 2017-08-22 Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion. MX2017010806A (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2017010806A MX2017010806A (es) 2017-08-22 2017-08-22 Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion.
PCT/MX2018/050020 WO2019039931A1 (es) 2017-08-22 2018-08-20 Formulación de ácido 18-beta-glicirretínico en combinación con revesterol y metformina, usos y método de fabricación
PCT/IB2018/056324 WO2019038678A1 (es) 2017-08-22 2018-08-21 Formulación de ácido 18-beta-glicirretínico en combinación con revesterol y metformina, usos, y método de fabricación

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017010806A MX2017010806A (es) 2017-08-22 2017-08-22 Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion.

Publications (1)

Publication Number Publication Date
MX2017010806A true MX2017010806A (es) 2018-01-18

Family

ID=61492274

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017010806A MX2017010806A (es) 2017-08-22 2017-08-22 Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion.

Country Status (2)

Country Link
MX (1) MX2017010806A (es)
WO (2) WO2019039931A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019009482A (es) * 2019-08-08 2021-02-09 Proyectos Atso S A P I De C V FORMAS FARMACEUTICAS DEL ACIDO 18ß-GLICIRRETINICO.
CN112370441B (zh) * 2020-11-24 2022-02-01 沈阳药科大学 白藜芦醇-天然产物组合物及其双磷脂复合物
MX2021012629A (es) * 2021-10-14 2023-04-17 Maria Esther Dragustinovis Ruiz Formulacion para el manejo y tratamiento antiviral, inmunomodulador y desinflamatorio de la infeccion por el virus del sars-cov2 (covid-19) y sus variante formulada a partir de la sal del acido glisirrisinico y sus deribados de su estructura química, asi como agentes antitusivos y anthistaminicos en jarabe.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX351117B (es) * 2011-02-25 2017-10-03 Desarrollos Vph S A De C V Formulacion de la sal acido glicirricinico en gel termorreversible y acido tricloroacetico para su aplicacion en el tracto genital de mujeres y varones con lesiones causadas por el virus del papiloma humano y cancer en los mismos.

Also Published As

Publication number Publication date
WO2019039931A1 (es) 2019-02-28
WO2019038678A1 (es) 2019-02-28

Similar Documents

Publication Publication Date Title
PH12015502539B1 (en) Cenicriviroc compositions and methods of making and using the same
WO2018033254A3 (en) Rna for cancer therapy
WO2014186742A3 (en) Anhydrous hydrogel composition
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
WO2014049447A3 (en) A whole, leech saliva extract
MX2017010806A (es) Formulacion de acido 18-beta-glicirretinico en combinacion con revesterol y metformina, usos y metodo de fabricacion.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
CL2016002276A1 (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
WO2015081319A3 (en) Activity enhancing curcumin compositions and methods of use
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
NZ587634A (en) Transdermal Patch
SA519410993B1 (ar) النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية
MX380429B (es) Composición para tratar lesiones tisulares.
CO2019008657A2 (es) Composición intranasal que comprende betahistina
CO2022002493A2 (es) Nanoemulsion de ácido 18p-glicirretínico
UA107155C2 (uk) Стабільна композиція для лікування герпесвірусних інфекцій
WO2016063265A3 (pt) Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos
CO7240380A2 (es) Composiciones líquidas orales pediátricas que contienen nepadutant
PH12020550029A1 (en) Topical formulations of chloroprocaine
CL2019002082A1 (es) Dispositivo médico para el tratamiento de infecciones cutáneas por pvh.
WO2014137231A3 (en) Totarol extract formulations and uses thereof
CL2017002601A1 (es) Composición para formulación cosmética humectante de larga duración que comprende manteca de ucuuba (virola surinamensis), en una concentración de 1-5% del total de manteca y altas concentraciones de ácido mirístico así como su uso para la preparación de productos cosméticos (con efecto de tacto seco y pulverulento) con alta capacidad humectante y kit.